Research Article

Artemisinin Reverses Glucocorticoid-Induced Injury in Bone Marrow-Derived Mesenchymal Stem Cells through Regulation of ERK1/2-CREB Signaling Pathway

Figure 7

Artemisinin attenuated DEXA-inhibitory osteogenesis differentiation of BMSCs. P3 BMSCs were seeded in 6-well plates at the density of 4- cells/mL, then treated with ART (1.0 μM), DEXA (30 μM), or ART (1.0 μM) + DEXA (30 μM) for 21 days. The formation of mineralized nodules was detected by ARS staining and observed using fluorescence microscopy (). (a) Representative images of ARS staining. (b) Quantification of the number of mineralized nodule number. (c) Quantification of the area in osteogenic differentiation using the ImageJ software (). and were considered significantly different. CTRL: control; ART: artemisinin; DEXA: dexamethasone; ART + DEXA: treated with artemisinin and then dexamethasone.
(a)
(b)
(c)